ADRA1D anticorps (3rd Cytoplasmic Domain)
Aperçu rapide pour ADRA1D anticorps (3rd Cytoplasmic Domain) (ABIN1731577)
Antigène
Voir toutes ADRA1D AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- 3rd Cytoplasmic Domain
-
Specificité
- Reacts with human ADRA1D
-
Réactivité croisée (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins.
-
Purification
- Antigen affinity purified
-
Immunogène
- Synthetic 20 amino acid peptide from 3rd cytoplasmic domain of human ADRA1D. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Monkey (100%), Marmoset (100%), Bovine (100%), Dog (100%), Bat (100%), Panda (100%)
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Working dilution: IHC - P (1 μg/mL - 3
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-80 °C
-
Stockage commentaire
- Long term: -70°C, Short term: +4°C
-
-
- ADRA1D (Adrenergic Receptor, alpha 1d (ADRA1D))
-
Autre désignation
- ADRA1D
-
Sujet
- This alpha-adrenergic receptor mediates its effect through the influx of extracellular calcium.
-
UniProt
- P25100
Antigène
-